市场简报新政出台，推进医药工业高端化、智能化、绿色化、融合化发展

Investment Rating - The report does not explicitly state an investment rating for the smart healthcare industry Core Insights - The smart healthcare industry is expected to experience significant growth driven by the integration of AI technologies and digital transformation initiatives in the pharmaceutical sector [4][19] - The market size of AI healthcare in China is projected to grow from 10.7 billion in 2023 to 97.6 billion by 2028, with a compound annual growth rate (CAGR) of 55.6% [19][20] - The implementation of the "Digital Transformation Implementation Plan for the Pharmaceutical Industry (2025-2030)" is a key driver for the development of smart healthcare, emphasizing the importance of AI in enhancing drug development and production efficiency [4][19] Summary by Sections Section 1: Market Potential and Growth Drivers - The AI healthcare market in China has grown from 2.7 billion in 2019 to 10.7 billion in 2023, with its share of the overall AI industry increasing from 6.4% to 8.6% [19] - The market is expected to reach 97.6 billion by 2028, capturing 15.4% of the AI industry [19] - Key growth drivers include uneven distribution of medical resources, policy support for digital transformation, and advancements in AI technology [19][20] Section 2: AI Applications in Smart Healthcare - AI applications in smart hospitals cover the entire patient journey, including AI triage, navigation, appointment scheduling, and follow-up services [6][7] - The integration of AI technologies is expected to reduce costs, improve diagnostic accuracy, and enhance service quality [7][11] Section 3: Business Models in AI Healthcare - Current business models in AI medical imaging include platform revenue sharing, software sales, and hardware-software integration [12][13] - The exploration of sustainable business models is crucial for the growth of the smart healthcare industry, with a focus on value-driven services and collaboration with insurance companies and pharmaceutical firms [14]